A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)



Status:Recruiting
Conditions:Infectious Disease, Nephrology, Urology
Therapuetic Areas:Immunology / Infectious Diseases, Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:7/14/2016
Start Date:January 2016
Contact:Clinical Trials Support
Email:clinical-trials@achaogen.com

Use our guide to learn which trials are right for you!

A Phase 3, Randomized, Multicenter, Double-Blind Study to Evaluate the Efficacy and Safety of Plazomicin Compared With Meropenem Followed by Optional Oral Therapy for the Treatment of Complicated Urinary Tract Infection (cUTI), Including Acute Pyelonephritis (AP), in Adults

This is a randomized, multicenter, multinational, double-blind study comparing the efficacy
and safety of plazomicin compared with meropenem followed by optional oral (PO) therapy in
the treatment of cUTI, including AP, in adults.


Key Inclusion Criteria:

- Pyuria

- Have a pretreatment baseline urine culture obtained within 36 hours before the start
of administration of the first dose of study drug

- Clinical signs and/or symptoms of acute pyelonephritis or complicated urinary tract
infection

- Normal renal function or moderate renal impairment

Key Exclusion Criteria:

- Confirmed fungal urinary tract infection at the time of randomization

- Known urinary tract infection or colonization with Gram-positive pathogens

- Current cUTI or AP is known to be caused by a pathogen resistant to meropenem

- Female patients of childbearing potential if they are known to be pregnant or have a
positive pregnancy test at screening, breastfeeding, or unable or unwilling to use a
highly effective method of birth control during the study and for at least 30 days
following the last dose of study medication

- Any rapidly progressing disease or immediately life-threatening illness

- Documented presence of immunodeficiency or an immunocompromised condition

- Documented or known history of otologic surgery or disease including use of hearing
aid, head injury leading to otologic damage, Ménière's disease, tumor of the head,
neck, or auditory system, perilymphatic fistula, or autoimmune disease of the inner
ear, or family history of hearing loss (excluding age-related hearing loss [onset
after age of 65 years])
We found this trial at
5
sites
St. Louis, Missouri
?
mi
from
St. Louis, MO
Click here to add this to my saved trials
Butte, Montana
?
mi
from
Butte, MT
Click here to add this to my saved trials
Florence, Alabama
?
mi
from
Florence, AL
Click here to add this to my saved trials
?
mi
from
Lima, OH
Click here to add this to my saved trials
?
mi
from
Montana,
Click here to add this to my saved trials